T. Rowe Price Associates’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33M | Sell |
760,844
-61,006
| -7% | -$2.65M | ﹤0.01% | 841 |
|
|
2025
Q1 | $30.7M | Sell |
821,850
-230,745
| -22% | -$8.62M | ﹤0.01% | 853 |
|
|
2024
Q4 | $47.7M | Buy |
1,052,595
+294,514
| +39% | +$13.3M | 0.01% | 772 |
|
|
2024
Q3 | $44.5M | Sell |
758,081
-10,140
| -1% | -$596K | 0.01% | 787 |
|
|
2024
Q2 | $30.2M | Sell |
768,221
-402,106
| -34% | -$15.8M | ﹤0.01% | 851 |
|
|
2024
Q1 | $77.8M | Buy |
1,170,327
+399,646
| +52% | +$26.6M | 0.01% | 606 |
|
|
2023
Q4 | $21.5M | Buy |
770,681
+154,731
| +25% | +$4.32M | ﹤0.01% | 935 |
|
|
2023
Q3 | $13.1M | Buy |
+615,950
| New | +$13.1M | ﹤0.01% | 1013 |
|